Report overview
Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.
This report aims to provide a comprehensive presentation of the global market for Anti-aging Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-aging Drugs. This report contains market size and forecasts of Anti-aging Drugs in global, including the following market information:
Global Anti-aging Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Anti-aging Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Anti-aging Drugs companies in 2022 (%)
The global Anti-aging Drugs market was valued at US$ 9078.5 million in 2022 and is projected to reach US$ 19310 million by 2029, at a CAGR of 11.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry's leading producers are Allergan, Galderma and LG Life Science, with revenue ratios of 41.40%, 16.45% and 8.36%, respectively, in 2019.
We surveyed the Anti-aging Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-aging Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-aging Drugs Market Segment Percentages, by Type, 2022 (%)
Dermal Fillers
Botulinum Toxin
Others
Global Anti-aging Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-aging Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Beauty Parlor
Others
Global Anti-aging Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Anti-aging Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-aging Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Anti-aging Drugs revenues share in global market, 2022 (%)
Key companies Anti-aging Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Anti-aging Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Galderma
LG Life Science
Merz Pharma
Medytox
Hugel
IMEIK
Haohai Bio
Daewoong Pharmaceutical
Bloomage
Suneva Medical
SciVision Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-aging Drugs, market overview.
Chapter 2: Global Anti-aging Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Anti-aging Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-aging Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Anti-aging Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
